Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013
Artesunate is the most effective treatment for severe malaria. However, delayed-onset hemolytic anemia has been observed in ≈20% of travelers who receive artesunate, ≈60% of whom require transfusion. This finding could discourage physicians from using artesunate. We prospectively evaluated a cohort...
Main Authors: | Stéphane Jauréguiberry, Marc Thellier, Papa Alioune Ndour, Flavie Ader, Camille Roussel, Romain Sonneville, Julien Mayaux, Sophie Matheron, Adela Angoulvant, Benjamin Wyplosz, Christophe Rapp, Thierry Pistone, Bénédicte Lebrun-Vignes, Eric Kendjo, Martin Danis, Sandrine Houzé, François Bricaire, Dominique Mazier, Pierre Buffet, Eric Caumes |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2015-05-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/21/5/14-1171_article |
Similar Items
-
Tratamento da malária com artesunate (retocaps®) em crianças da Amazônia brasileira Malaria treatment with artesunate (retocaps®) in children of the Brazilian Amazon
by: Maria das Graças Costa Alecrim, et al.
Published: (2000-04-01) -
Artesunate-, sulfadoxine-, and pyrimethamine-induced cardiotoxicity
by: Divya Goel, et al.
Published: (2016-01-01) -
The Other Face of Artesunate: Southern Drug to Treat Northern Diseases
by: Stephane Picot
Published: (2015-01-01) -
Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
by: Leonardo J. M. Carvalho, et al.
Published: (2020-07-01) -
Stimulation of Suicidal Erythrocyte Death by Artesunate
by: Kousi Alzoubi, et al.
Published: (2014-12-01)